Patents by Inventor Shannon Okada

Shannon Okada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-17C ANTAGONISTS AND METHODS OF USING THE SAME
    Publication number: 20070129302
    Abstract: The present invention relates IL-17RE antagonists, such as soluble receptors and anti-IL-17RE antibodies, that are useful in blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17C. IL-17C is a cytokine that is involved in inflammatory processes and human disease. IL-17RE is a receptor for IL-17C. The present invention includes soluble IL-17RE, anti-IL-17RE antibodies and binding partners, as well as methods for antagonizing IL-17C using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 18, 2006
    Publication date: June 7, 2007
    Inventors: Zeren Gao, Rolf Kuestner, Mark Appleby, Katherine Lewis, Patricia McKernan, Shannon Okada, David Taft, Joseph Kuijper, Stephen Jaspers, Steven Levin
  • SOLUBLE ZCYTOR21, ANTI-ZCYTOR21 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
    Publication number: 20070049525
    Abstract: The present invention relates ZcytoR21 antagonists, such as soluble receptors and anti-ZcytoR21 antibodies, that are useful in blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17C. IL-17C is a cytokine that is involved in inflammatory processes and human disease. ZcytoR21 is a receptor for IL-17C. The present invention includes soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners, as well as methods for antagonizing IL-17C using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 4, 2006
    Publication date: March 1, 2007
    Inventors: Zeren Gao, Rolf Kuestner, Mark Appleby, Katherine Lewis, Patricia McKernan, Shannon Okada, David Taft, Joseph Kuijper, Stephen Jaspers, Steven Levin
  • SOLUBLE ZCYTOR21, ANTI-ZCYTOR21 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION
    Publication number: 20070049524
    Abstract: The present invention relates ZcytoR21 antagonists, such as soluble receptors and anti-ZcytoR21 antibodies, that are useful in blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17C. IL-17C is a cytokine that is involved in inflammatory processes and human disease. ZcytoR21 is a receptor for IL-17C. The present invention includes soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners, as well as methods for antagonizing IL-17C using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 4, 2006
    Publication date: March 1, 2007
    Inventors: Zeren Gao, Rolf Kuestner, Mark Appleby, Katherine Lewis, Patricia McKernan, Shannon Okada, David Taft, Joseph Kuijper, Stephen Jaspers, Steven Levin
  • Methods of delivering corticotroph-derived glycoprotein hormone
    Publication number: 20070014736
    Abstract: Methods for treating diseases comprising delivering CGH by aerosol delivery and comprising administering a lesser amount of CGH than TSH are described.
    Type: Application
    Filed: June 21, 2006
    Publication date: January 18, 2007
    Inventors: Shannon Okada, Katherine Lewis, Jeff Ellsworth
  • Soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners and methods of using in inflammation
    Publication number: 20060142192
    Abstract: The present invention relates ZcytoR21 antagonists, such as soluble receptors and anti-ZcytoR21 antibodies, that are useful in blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-17C. IL-17C is a cytokine that is involved in inflammatory processes and human disease. ZcytoR21 is a receptor for IL-17C. The present invention includes soluble ZcytoR21, anti-ZcytoR21 antibodies and binding partners, as well as methods for antagonizing IL-17C using such soluble receptors, antibodies and binding partners.
    Type: Application
    Filed: October 18, 2005
    Publication date: June 29, 2006
    Inventors: Zeren Gao, Rolf Kuestner, Mark Appleby, Katherine Lewis, Patricia McKernan, Shannon Okada, David Taft, Joseph Kuijper, Stephen Jaspers, Steven Levin